News for 'pharmaceutical'

PM to meet COVID-19 vaccine manufacturers on today

PM to meet COVID-19 vaccine manufacturers on today

Rediff.com20 Apr 2021

During the meeting, scheduled to be held through video conference at 6 pm on Tuesday, the Department of Biotechnology will make a presentation and also coordinate with all the participants, sources added.

'We are advising multi-cap or large-cap strategy'

'We are advising multi-cap or large-cap strategy'

Rediff.com12 Jan 2022

Neelesh Surana, who manages Mirae Asset Tax Saver and Mirae Asset Emerging Bluechip, remains constructive on Indian equities from a three to five-year time frame.

August 4 was the busiest day for IPOs since 2007

August 4 was the busiest day for IPOs since 2007

Rediff.com5 Aug 2021

Retail investors-those investing up to Rs 200,000-lapped up all the four initial public offerings (IPOs) that opened for subscription on Wednesday. This is the first time since 2007 that four IPOs have been launched on a single day, according to information provided by Prime Database. KFC and Pizza Hut franchisee Devyani International (size Rs 1,838 crore); Diagnostic chains Krsnaa Diagnostics (Rs 1,213 crore), pharmaceutical firm Windlas Biotech (Rs 401 crore) and vitrified tiles manufacturer Exxaro Tiles (Rs 161 crore) are the four companies whose IPOs opened on Wednesday.

'I never thought that it's a pandemic story'

'I never thought that it's a pandemic story'

Rediff.com7 Sep 2022

'I never thought the European audience will love this film, but we had over 2,000 people at the screening.'

PM to chair all-party meet on COVID on December 4

PM to chair all-party meet on COVID on December 4

Rediff.com30 Nov 2020

This will be the second all-party meeting called by the government to discuss the COVID-19 situation since the outbreak of the pandemic.

Pharma majors shift focus to inhalants, nasal spray for Covid

Pharma majors shift focus to inhalants, nasal spray for Covid

Rediff.com30 Aug 2021

While Lupin is working on a Remdesivir powder for inhalation, Glenmark has tied up with a Canadian Biotech firm for nitric oxide nasal spray that reduces Sars-CoV-2 viral load and thus transmission.

Govt lifts expenditure curbs linked to Covid-19

Govt lifts expenditure curbs linked to Covid-19

Rediff.com24 Sep 2021

The finance ministry on Friday withdrew expenditure curbs on various departments and ministries imposed in June in the wake of the COVID-19 second wave, reflecting improvement in public finances and the urgency to step up growth.

'Growth will definitely be less than 8%'

'Growth will definitely be less than 8%'

Rediff.com23 May 2022

'There will be positive growth, but if you ask me whether we are going to have the original growth rate of 8%, the answer will be, no.'

Taliban stop exports, imports from India

Taliban stop exports, imports from India

Rediff.com18 Aug 2021

The Taliban have stopped all imports and exports with India after entering Kabul and taking over the country on Sunday. Ajay Sahai, Director General (DG) of Federation of Indian Export Organisation (FIEO) told ANI that currently, the Taliban has stopped the movement of cargo through the transit routes of Pakistan, thereby stopping imports from the country.

PE/VC investments decline 22% to $5.4 bn in June

PE/VC investments decline 22% to $5.4 bn in June

Rediff.com19 Jul 2021

Investments by private equity and venture capital funds declined by 22 per cent to $5.4 billion in June, as compared to the $6.9 billion in the year-ago period, a report said on Monday. However, if compared with May's $4 billion, the investments were higher by 33 per cent, the monthly report by industry lobby group IVCA and consultancy firm EY said. If one were to compare the inflows into companies in the first half of 2021, the investments were 45 per cent higher at $26.9 billion.

Govt gifts Rs 1.45-trillion incentive for 10 manufacturing sectors

Govt gifts Rs 1.45-trillion incentive for 10 manufacturing sectors

Rediff.com12 Nov 2020

The government hopes that the PLI schemes would provide 200,000-300,000 direct employment over five years, according to sources in the know.

Modi: 'We need wealth creators to even distribute wealth'

Modi: 'We need wealth creators to even distribute wealth'

Rediff.com11 Feb 2021

Demoralising the private companies and disregarding their contribution won't do any good to the country or its youth as our experience has shown that private enterprises in mobile manufacturing has lead to every poor family owning a mobile phone now, while the country's private sector in the pharmaceutical space has been serving humanity through vaccines and medicines during Covid times, Modi said.

Healthcare sector likely to reach $372 bn in 2022: Niti

Healthcare sector likely to reach $372 bn in 2022: Niti

Rediff.com30 Mar 2021

Healthcare has become one of the largest sectors of the Indian economy and is expected to reach $372 billion in 2022, according to a report by Niti Aayog released on Tuesday. The report outlined a range of investment opportunities in the country's healthcare sector across hospitals, pharmaceuticals and medical devices. The report, titled 'Investment Opportunities in India's Healthcare Sector', also said India's healthcare sector has the potential to generate 27 lakh jobs in India between 2017 and 2022 -- over 5 lakh new jobs per year.

Data leak shows massive infiltration by China's Communist Party

Data leak shows massive infiltration by China's Communist Party

Rediff.com14 Dec 2020

The data leak obtained by 'The Australian' newspaper has revealed how the alleged CPC members are employed with some of the world's biggest corporations in the areas of defence, banks and pharmaceutical giants manufacturing coronavirus vaccines.

PM holds meet with teams involved in developing COVID vaccine

PM holds meet with teams involved in developing COVID vaccine

Rediff.com30 Nov 2020

The teams were from Gennova Biopharmaceuticals Ltd Pune, Biological E Ltd Hyderabad and Dr Reddys Laboratories Ltd Hyderabad.

3 lakh remdesivir to be produced daily in 15 days: Govt

3 lakh remdesivir to be produced daily in 15 days: Govt

Rediff.com18 Apr 2021

The government has also given permission to 20 plants to produce the antiviral drug.

Expert panel grants nod to study on mixing Covaxin, Covishield

Expert panel grants nod to study on mixing Covaxin, Covishield

Rediff.com30 Jul 2021

The panel also recommended giving approval to Bharat Biotech for carrying out a study on interchangeability of its Covaxin and the under-trial adenoviral intranasal vaccine candidate BBV154, but asked the Hyderabad-based firm to remove the word "interchangeability" from the study title and submit a revised protocol for approval.

Exports jump 60% in March; falls over 7% in FY21

Exports jump 60% in March; falls over 7% in FY21

Rediff.com15 Apr 2021

The country's exports jumped by 60.29 per cent to $34.45 billion in March even as the outbound shipments contracted by 7.26 per cent during the full 2020-21 fiscal to $290.63 billion. Imports too grew by 53.74 per cent to $48.38 billion in March, but dipped by 18 per cent to $389.18 billion during April-March 2020-21, according to the government data released on Thursday. Trade deficit during March 2021 widened to $13.93 billion from $9.98 billion in March 2020.

India remains an attractive FDI destination

India remains an attractive FDI destination

Rediff.com14 Sep 2021

India remains an attractive destination for foreign direct investments (FDI) on account of healthy prospects of economic growth and its skilled workforce, according to a survey by Deloitte. A large proportion of international business leaders remain confident in India's short- and long-term prospects and are readying plans to make additional and first-time investments in the country, it said on Tuesday. "The survey, which questioned 1,200 business leaders of multinational corporations in the US, UK, Japan and Singapore, found that India remains an attractive destination for investments, scoring highly for its skilled workforce and prospects for economic growth," the survey - India's FDI Opportunity - said.

Crisil ups India Inc's credit outlook to 'positive'

Crisil ups India Inc's credit outlook to 'positive'

Rediff.com18 Aug 2021

Crisil Ratings on Wednesday said a broad-based recovery is on for India Inc currently, and upgraded its credit quality outlook to 'positive' from the earlier 'cautiously optimistic'. The rating agency said the credit ratio, which illustrates the number of upgrades to downgrades, rose to over 2.5 times in the first four months of the fiscal, as compared to 1.33 times in the second half of FY21, it said in a statement. The rating agency said it has also done a study of 43 sectors, excluding the financial sector, accounting for 75 per cent of the overall Rs 36 lakh crore in outstanding debt, which shows that the current recovery is broad-based.

Adani, Goenka could lead the charge at IPL team bidding

Adani, Goenka could lead the charge at IPL team bidding

Rediff.com24 Oct 2021

The BCCI will be expecting the two new IPL franchises to go for Rs 7000 crore to Rs 10,000 crore each at the bidding process which begins in Dubai on Monday.

Covid Vaccine IP: How Big Pharma lobbied against India

Covid Vaccine IP: How Big Pharma lobbied against India

Rediff.com9 Jun 2021

Communications between the USTR and the world's most powerful pharmaceutical and trade lobbying groups reveal that many raised concerns about India's push to exempt Covid vaccines from intellectual property.

Covishield booster works against Omicron

Covishield booster works against Omicron

Rediff.com24 Dec 2021

If the vaccine is recommended for use as a booster against Omicron, it may significantly boost the demand for Covishield in India.

India, US committed to taking on toughest challenges together: Biden after meeting Modi

India, US committed to taking on toughest challenges together: Biden after meeting Modi

Rediff.com25 Sep 2021

India and the US are the world's largest democracies and the two countries are committed to taking on the toughest challenges together, President Joe Biden said after his first-ever in-person meeting with Prime Minister Narendra Modi at the White House.

India may not buy Pfizer, Moderna vaccines

India may not buy Pfizer, Moderna vaccines

Rediff.com23 Sep 2021

Though there is no official word, the sources said the government is not ready to give in to the indemnity demands of the US drug manufacturers against liabilities in case of adverse effects.

Coronavirus may impact India's Q4 GDP growth

Coronavirus may impact India's Q4 GDP growth

Rediff.com2 Mar 2020

Sectors such as electronics, pharmaceuticals and automobiles can see supply disruptions in value chain, which may lead to a derailment of the domestic economic growth.

Hiring sentiment highest in India, 17% firms keen on freshers: Survey

Hiring sentiment highest in India, 17% firms keen on freshers: Survey

Rediff.com22 Sep 2021

Fresher hiring sentiment is highest in India, with 17 per cent employers keen on recruiting fresh graduates in the July to December 2021 period against 6 per cent globally. According to the Career Outlook Report by TeamLease EdTech, conducted across 18 sectors and 14 cities, the hiring sentiment in the country has registered a 2 percentage point increase over the February-April 2021 period. In terms of sectors, those that have been able to withstand the impact of the pandemic and witnessed a stronger hiring sentiment are information technology (31 per cent), telecommunication (25 per cent) and technology start-ups (25 per cent).

Govt accepts Cairn's offer on retro tax

Govt accepts Cairn's offer on retro tax

Rediff.com18 Nov 2021

Moving quickly towards ending a retrospective tax dispute with a firm that gave India its largest oilfield, the government has accepted Cairn Energy PLC's undertakings which would allow for the refund of taxes, sources said. Meeting the requirements of the new legislation that scraps levy of retrospective taxation, the company had earlier this month given required undertakings indemnifying the Indian government against future claims as well as agreeing to drop any legal proceedings anywhere in the world. The government has now accepted this and issued Cairn a so-called Form-II, committing to refund the tax collected to enforce the retrospective tax demand, two sources with direct knowledge of the development said.

India pays Cairn Rs 7,900 cr to settle retro tax dispute

India pays Cairn Rs 7,900 cr to settle retro tax dispute

Rediff.com24 Feb 2022

The Indian government has paid Cairn Energy Plc Rs 7,900 crore to refund taxes it had collected to enforce a retrospective tax demand, ending a seven-year-old dispute that had tarred the country's image as an investment destination. The company, which is now known as Capricorn Energy PLC, in a statement said it has received "net proceeds of $1.06 billion", of which nearly 70 per cent will be returned to the shareholders. The tax department had used a 2012 legislation, which gave it powers to go back 50 years and slap capital gains levies wherever ownership had changed hands overseas but business assets were in India, to seek Rs 10,247 crore in taxes from Cairn.

Traders seek Army's help to distribute medicines

Traders seek Army's help to distribute medicines

Rediff.com31 Mar 2020

The situation is severe in North India as most of the logistics operation was manned by migrant labourers from Uttar Pradesh and Bihar. The problem with manpower is not only in courier and delivery services, but also at a shop level.

Pakistan to let fully-vaccinated Sikh pilgrims visit Kartarpur Sahib with strict protocols

Pakistan to let fully-vaccinated Sikh pilgrims visit Kartarpur Sahib with strict protocols

Rediff.com22 Aug 2021

The decision to open Kartarpur shrine was taken by the National Command and Operation Centre (NCOC) on Saturday due to the approaching death anniversary of Sikhism founder Baba Guru Nanak Dev on September 22.

Covid vaccines for children likely by Sept: AIIMS chief

Covid vaccines for children likely by Sept: AIIMS chief

Rediff.com24 Jul 2021

The trial is being conducted in three phases by segregating children into categories according to their age. The first trial was started in the age group of 12 to 18 years followed by the age group of 6 to 12. Trials for children between the ages of and 2-6 years are currently undergoing trials.

Tatas, Adani, Ambanis in scramble for super app

Tatas, Adani, Ambanis in scramble for super app

Rediff.com8 Nov 2021

The groups plan to take on well-entrenched players like Amazon, Flipkart, and Paytm by merging their offline businesses with e-commerce initiatives.

Consumption funds: Go for a maximum 5-10% exposure, say experts

Consumption funds: Go for a maximum 5-10% exposure, say experts

Rediff.com28 Sep 2021

Consumption is among the most diversified and sought-after themes in Indian equities. Over the past five years, consumption theme funds have given an annualised category average return of 15.17 per cent, according to the data from Value Research. But this theme has been affected by the Covid-19 pandemic, which impacted jobs and livelihood.

From earning Rs 300 to associate general manager

From earning Rs 300 to associate general manager

Rediff.com5 Feb 2020

Rediff reader K Srinivasan, 54 who works as associate general manager, corporate relations at BGS Gleneagles Global Hospitals in Bengaluru shares his story.

Mumbai still home to most of India's richest

Mumbai still home to most of India's richest

Rediff.com2 Oct 2018

Pharmaceuticals, along with software and services, also added the most new entrants on the rich list 2018.

PE/VC investments in pharma cos cross $1 bn mark

PE/VC investments in pharma cos cross $1 bn mark

Rediff.com6 Oct 2020

Fund managers said investors remained positive on the pharma manufacturing activity in India, which further strengthened during the Covid-19 period, on account of restrictions imposed on pharma imports from China.

Why prices of vitamin C, antibiotics could shoot up

Why prices of vitamin C, antibiotics could shoot up

Rediff.com14 Dec 2019

The government said that "in exercise of extraordinary powers in public interest, conferred by paragraph 19 of the DPCO, 2013", the ceiling prices of 21 key formulations had been increased. These formulations include common medicines like BCG vaccines, penicillin, malaria and leprosy medicines (Dapsone), life-saving drugs like Furosemide (used to treat fluid build-up due to heart failure, liver scarring, or kidney disease), vitamin C, some common antibiotics, and anti-allergy medicines.

Production of 1 bn vax doses in India on track: Biden

Production of 1 bn vax doses in India on track: Biden

Rediff.com23 Sep 2021

The Quad partnership is on track to produce at least a billion vaccine doses in India by 2022, US President Joe Biden said on Wednesday, asserting that nothing is more urgent than working together to defeat COVID-19 so the world is much better prepared for future pandemics.

8 vaccines, 4 treatments in India's COVID-19 arsenal

8 vaccines, 4 treatments in India's COVID-19 arsenal

Rediff.com28 Dec 2021

The Central Drugs Standard Control Organisation has granted restricted emergency use authorisation to two new vaccines and a drug for COVID-19, taking the number of preventives and treatments available in India to 12.